Ketamine therapy cost in 2026: what you actually pay out of pocket
Ketamine clinic pricing ranges from $150 oral lozenges at home to $950 per Spravato session. Here is what each route costs, what insurance actually covers, and how to use HSA/FSA to cut the real number.
LicensedPsychedelics Editorial
Editorial team·How we verify
TL;DR
- IV ketamine: $400-$600 per session, 6-session induction runs $2,400-$3,600 cash. Insurance coverage is rare outside Spravato.
- IM ketamine: $300-$450 per session. Same induction logic. Same limited insurance.
- Oral/at-home via telehealth: $150-$300 per month for a full program including the prescriber and the medicine.
- Spravato (FDA-approved): $475-$950 per session gross, but commercial insurance covers most of it. Out-of-pocket is usually the coinsurance + deductible.
- HSA/FSA are eligible for every route. Ask the clinic for an itemized superbill with ICD-10 F33.2.
Ketamine is prescribed four different ways in the United States, each priced completely differently. Before your first consult, get the real number straight - a ketamine clinic's front desk will almost always give you the per-session sticker, not the total you will actually pay across a 6-session induction plus any follow-up maintenance.
This is the 2026 price reality across the four delivery routes, and the specific questions to ask before you commit.
IV ketamine (in-clinic infusion)
The best-studied route. Cash price at most US clinics runs $400-$600 per 40-minute infusion. A standard induction for depression is 6 sessions over 2-3 weeks, so the real first-month cost is $2,400-$3,600. Maintenance sessions thereafter run every 2-6 weeks depending on response, typically at the same per-session rate.
Insurance coverage for off-label IV ketamine is rare. A handful of commercial plans in WA, CA, MN and NY have begun paying for a limited number of sessions after a Spravato failure or contraindication, but that is the exception - most IV ketamine in 2026 is still cash-pay. Some clinics bill the consultation and monitoring to insurance (CPT 99214 + 99354) even when the drug itself is not covered, which can cut the effective cost 15-30%.
IM ketamine
Intramuscular injection is typically $300-$450 per session. Same induction structure as IV. Same insurance reality - rare direct coverage for the drug, occasional coverage for the visit and monitoring codes. For cost-sensitive patients, IM is the most common substitute for IV at well-run clinics.
Oral lozenges via telehealth
At-home oral ketamine programs from Mindbloom, Joyous, Better U, Innerwell, and similar services bundle the prescriber visit, shipped lozenges, and remote integration sessions into a single monthly fee. Typical range: $150-$300 per month for the first 1-3 months, then $100-$200 per month for maintenance. For a side-by-side with state coverage and who each program is a fit for, see our [at-home ketamine comparison](/at-home-ketamine).
Telehealth oral programs do not involve an in-person clinic, which is both the feature (low cost, convenience) and the tradeoff (no hands-on monitoring, variable absorption, less suited to severe depression). Most of these services accept HSA/FSA.
Spravato (the only insurance-covered psychedelic)
Spravato is the FDA-approved esketamine nasal spray. The list price per session is $475-$950, but because it is FDA-approved and REMS-certified, commercial insurance, Medicare Part B, and Medicaid in many states cover it. Your real out-of-pocket depends on your plan structure:
Commercial PPO with deductible already met: specialist copay, usually $30-$75 per session. Commercial HDHP before deductible: full allowed amount applies to your deductible until met. Medicare Part B: 20% coinsurance unless you carry Medigap. Medicaid (in a covering state): typically $0-$5 per session.
Induction is 8 sessions over 4 weeks, maintenance drops to weekly then biweekly. If you have strong commercial coverage, Spravato is often the cheapest clinically-monitored path by a wide margin. See our [Spravato coverage guide](/blog/spravato-insurance-coverage-2026) for the plan-by-plan breakdown.
HSA and FSA rules
Every route above is an HSA- and FSA-eligible medical expense when you have a PHQ-9 or similar documented diagnosis. Keep the itemized superbill with the ICD-10 code (F33.2 for recurrent MDD is the most common), the CPT codes for the visit and monitoring, and the drug NDC code if applicable. Your HSA administrator may ask for documentation at tax time.
If your employer offers a Limited Purpose FSA (LPFSA), ketamine is not covered - LPFSAs are dental and vision only. A regular Healthcare FSA and an HSA both work.
What to ask the clinic before booking
Four questions will give you the real number:
1. What is the per-session price, and what is the total cost of a full induction series?
2. What is billable to insurance - the drug, the monitoring, the prescriber visit, or none?
3. Under the No Surprises Act, can I have a good-faith estimate in writing before my first session?
4. Do you accept HSA/FSA, CareCredit, or offer sliding-scale pricing?
Any clinic that cannot answer those four in a single phone call is not giving you enough information to commit. Our verified clinics publish a pricing sheet; that is one of the things we check in the verification pass.
The cheapest clinically-appropriate path
In order of total annual cost for a typical patient responding to treatment:
Telehealth oral lozenges: ~$1,800-$3,600 per year. Spravato with strong commercial insurance: ~$600-$2,400 per year out of pocket. Medicaid-covered Spravato in a covering state: under $300 per year. Cash IM ketamine (induction + monthly maintenance): ~$4,500-$7,000 per year. Cash IV ketamine (induction + monthly maintenance): ~$6,000-$9,000 per year.
Cheapest is not the same as clinically appropriate. If you have severe or treatment-resistant depression, the IV and Spravato paths have the strongest evidence and are worth the cost difference over at-home oral for most patients. Talk with a prescriber who has walked other patients through all four routes before locking in.